The Wharton School, University of Pennsylvania, Aresty Institute of Executive Education (2020)
Weatherhead School of Management, Case Western Reserve University (1999)
Fellowship, Hepatic Transplantation Anesthesiology, University Health Sciences Center, University of Pittsburgh (1997)
Residency, Anesthesiology, University Health Sciences Center, University of Pittsburgh (1996)
Internship, Internal Medicine, Millard Fillmore Hospital, State University of New York at Buffalo (1993)
BS, State University of New York at Buffalo, Cum Laude (1988)
Employment:
Clinical Professor of Anesthesiology, Anesthesiology, Jacobs School of Medicine and Biomedical Sciences State University of New York at Buffalo (2024-present)
President and CEO, University at Buffalo Anesthesiology, Inc., Anesthesiology, Jacobs School of Medicine and Biomedical Sciences, State University of New York at Buffalo (2024-present)
Senior Associate Dean for Clinical Affairs, Jacobs School of Medicine and Biomedical Sciences State University of New York at Buffalo (2024-present)
Chief Medical Officer, UBMD Physicians' Group, Jacobs School of Medicine and Biomedical Sciences, State University of New York at Buffalo (2024-present)
Clinical Lead, Quality, Safety & Value Strategy, Metrics and Goals, Highmark Health (2021–2024)
Chief Quality & Learning Officer, Allegheny Health Network (2020–2024)
Staff Anesthesiologist, Allegheny Health Network (2017–2024)
Clinical Professor (Adjunct) of Anesthesiology, Anesthesiology, Lewis Katz School of Medicine at Temple University (2017–2020)
Chief Quality Officer, Allegheny Health Network (2019)
Chief Medical & Quality Officer, Allegheny Health Network (2018)
Associate Chief Medical Officer, Allegheny Health Network (2017)
Associate Professor of Anesthesiology, Anesthesiology, Cleveland Clinic Lerner College of Medicine at Case Western Reserve University (2005–2017)
Hashimoto K, Eghtesad B, Gunasekaran G, Fujiki M, Uso TD, Quintini C, Aucejo FN, Kelly DM, Winans CG, Vogt DP, Parker BM, Irefin SA, Miller CM, Fung JJ. (2010) Use of tissue plasminogen activator in liver transplantation from donation after cardiac death donors. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons (Dec), 10(12): 2665-72.
Parker BM, Dishart MK, Pinsky MR, Kang Y. (1999) Is there occult tissue ischemia in chronic end-stage liver disease?. Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society (May), 5(3): 211-8.